Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Atmofizer Technologies Inc C.ATMO

Alternate Symbol(s):  ATMFF

Atmofizer Technologies Inc. (Atmofizer) is a Canada-based company. The Company's consumer and industrial solutions are based on its technology for ultrafine particle agglomeration and neutralization. This capability creates a method for addressing a range of nano-scale particles, viruses and bacteria. Atmofizer develops technology to atmofize air and applies its technology in consumer and industrial air purification products that are manufactured under the Atmofizer brand, as well as in retail and commercial devices produced by other companies that integrate Atmofizer technology into their own products. The Company's range of products includes wearable, portable and mobile use for personal air treatment, as well as larger systems to handle higher air volumes for commercial, industrial, institutional, and residential applications.


CSE:ATMO - Post by User

Post by mingzhuon Jan 17, 2022 7:15pm
277 Views
Post# 34326517

Here is why Vaxx keeps selling: 35M shares at 0.02 usd

Here is why Vaxx keeps selling: 35M shares at 0.02 usdConcurrently with the execution of the 2020 IP Agreements on October 26, 2020, Vaxxinator completed a non-brokered private placement of an aggregate of 35,250,000 Vaxxinator Shares at a price of US $0.02 per share for gross proceeds of US$705,000.

Between December 4, 2020 and February 5, 2021, Vaxxinator completed a non-brokered private placement of Vaxxinator Shares in multiple tranches whereby an aggregate of 8,820,000 Vaxxinator Shares were issued and sold at a price of US$0.50 per share for aggregate gross proceeds of US$4,410,000.
<< Previous
Bullboard Posts
Next >>